Skip to menu Skip to content Skip to footer
Dr Jacky Suen
Dr

Jacky Suen

Email: 
Phone: 
*

Overview

Background

Critical Care Medicine focuses on supporting patients, often with one or multiple organ failures. Based at the largest Australian cardiac hospital, our research investigates better ways to support patients with heart and/or lung failure. We explore technological, pharmacological and engineering advances that could help our patients to live longer and better. Our group is world-renowned for clinically relevant large animal models, including heart failure, respiratory failure (ARDS), heart transplantation, sepsis, cardiogenic shock, and more. All our studies use hospital-grade equipment and follow the same clinical guideline to maximise translation. We actively take on honours, MPhil and PhD students from multi-disciplinary backgrounds (science, engineering, medicine, allied health), with a successful track record in supporting our students to secure their own grants and funding. Students are expected to contribute to other studies of the group. For more information about the group, please visit ccrg.org.au, and email if you are interested to join us.

Availability

Dr Jacky Suen is:
Available for supervision
Media expert

Qualifications

  • Bachelor (Honours) of Science (Advanced), The University of Queensland
  • Doctor of Philosophy of Pharmacology, The University of Queensland
  • Member, Extracorporeal Life Support Organization, Extracorporeal Life Support Organization

Works

Search Professor Jacky Suen’s works on UQ eSpace

225 works between 2007 and 2025

221 - 225 of 225 works

2010

Conference Publication

Protease-activated receptor-2 and renal carcinogenesis

Vesey, D., Rajandram, R., Blakeney, J., Suen, J., Johnson, D., Fairlie, D. and Gobe, G. (2010). Protease-activated receptor-2 and renal carcinogenesis. 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth Convention and Exhibition Centre, Perth, Western Australia, 12-15 September 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2010.01377_1.x

Protease-activated receptor-2 and renal carcinogenesis

2010

Conference Publication

A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial Cells

Vesey David A., Suen, Jacky Yung, Johnson, David W. and Fairlie, David (2010). A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial Cells. Kidney Week, American society of Nephrology, Denver Colorado USA, November 16 - 21. Journal of the American Society of Nephrology:

A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial Cells

2009

Conference Publication

Regulating protein and peptide activated GPCRs

Fairlie, David P., Madala, Praveen K., Stoermer, Martin J., Suen, Jacky, Barry, Grant and Lohman, Rink-Jan (2009). Regulating protein and peptide activated GPCRs. 229th National Meeting of the American Chemical Society, San Diego, California, 13-17 March 2005. Washington DC, United States: American Chemical Society.

Regulating protein and peptide activated GPCRs

2008

Other Outputs

Regulating protease activated receptor 2

Suen, Jacky Yung (2008). Regulating protease activated receptor 2. PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. doi: 10.14264/uql.2014.212

Regulating protease activated receptor 2

2007

Journal Article

A refined agonist pharmacophore for protease activated receptor 2

Barry, Grant D., Suen, Jacky Y., Low, Heng Boon, Pfeiffer, Bernhard, Flanagan, Bernadine, Halili, Maria, Le, Giang T. and Fairlie, David P. (2007). A refined agonist pharmacophore for protease activated receptor 2. Bioorganic & Medicinal Chemistry Letters, 17 (20), 5552-5557. doi: 10.1016/j.bmcl.2007.08.026

A refined agonist pharmacophore for protease activated receptor 2

Funding

Current funding

  • 2025 - 2026
    PRIMELab Research Fellowship
    Prince Charles Hospital Foundation
    Open grant
  • 2025 - 2026
    Completing the Loop: Unravelling Complement-Driven Interleukin Cascades in an Extracorporeal Membrane Oxygenation (ECMO) Blood Model
    Prince Charles Hospital Foundation
    Open grant
  • 2025 - 2027
    Load Incorporating Cardiac Assessment by Echocardiography to Refine Outcome Predictions In Patients with SEpsis: Prospective Multicentre Study (LIAISE study)
    TPCH Foundation Innovation Grants
    Open grant
  • 2025 - 2027
    Towards Equitable Monitoring in the ICU - Reducing Racial Bias of Pulse Oximeters with Corrective Algorithms
    TPCH Foundation Innovation Grants
    Open grant
  • 2024 - 2029
    Research Equipment for the Critical Care Research Group at IMB
    The Common Good and the Sheila & Bernard Joel Life Saving Medical Equipment Foundation
    Open grant
  • 2024 - 2026
    Impact of Blood Flow Dynamics on endocrine function of Lung Epithelial and Endothelial Cell: Pulsatile vs. Continuous Flow Analysis
    The Prince Charles Hospital Foundation New Investigator Grant
    Open grant
  • 2024 - 2026
    ALL IN - AI and Laboratory Led IdentificatioN of PASC
    NHMRC MRFF Post-Acute Sequelae of COVID-19
    Open grant
  • 2024 - 2026
    Addressing deficiencies of current ECMO with an innovative pulsatile flow technology (ADEPT)
    National Heart Foundation Vanguard Grant
    Open grant
  • 2024 - 2027
    Mitochondrial Transplantation as a supplementary therapy for heart transplantation: A Novel Strategy to Enhance Donor HeartFunction
    National Heart Foundation Vanguard Grant
    Open grant
  • 2023 - 2026
    Critical Care Translational Research
    Prince Charles Hospital Foundation
    Open grant
  • 2023 - 2027
    Effect of mitochondrial transplantation following hypothermic machine perfusion on donor heart ischemic time
    Prince Charles Hospital Foundation
    Open grant
  • 2023 - 2027
    Heart Ex Vivo Perfusion
    The Donald & Joan Wilson Foundation Ltd
    Open grant
  • 2023 - 2026
    Hypothermic machine perfusion of circulatory death hearts for transplantation
    NHMRC IDEAS Grants
    Open grant
  • 2021 - 2025
    Living Heart Project CCRG
    The Donald & Joan Wilson Foundation Ltd
    Open grant

Past funding

  • 2024 - 2025
    An exploration of protein profile underlying the therapeutic effect of hydrogen gas in an ovine model of severe acute lung injury
    The Prince Charles Hospital Foundation New Investigator Grant
    Open grant
  • 2024 - 2025
    Assessment of blood trauma in pulsatile vs. continuous flow ECMO in an ex-vivo model.
    The Prince Charles Hospital Foundation New Investigator Grant
    Open grant
  • 2024
    2023 Equipment grant - OxyLiteTM/OxyFloTM combined 4 Channel tissue pO2 and temperature monitor with touch screen
    Prince Charles Hospital Foundation
    Open grant
  • 2022 - 2024
    Developing FXIIa inhibitors as next-generation anticoagulants
    NHMRC Development Grant
    Open grant
  • 2022
    Rogue mitochondrial DNA: The elusive mediator of inflammatory complications in cardiac surgery
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2023
    Toward routine blood test for early cardiovascular disease detection.
    Advance Queensland Industry Research Fellowships
    Open grant
  • 2020 - 2022
    Advancing knowledge in cardiac surgery-associated organ complications: Confronting the dark side of cell-free mitochondrial DNA (Collaborative Research Grant administered by MNHHS)
    Metro North Hospital and Health Service
    Open grant
  • 2020 - 2024
    COVID19 Critical Care Consortium (incorporating ECMOcard) data analysis
    Prince Charles Hospital Foundation
    Open grant
  • 2019
    Advanced Haemodynamic Monitoring for Large Animal Experimentation
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Modulating Inflammatory and fibrogenic pathways in kidney disease using a novel antagonist of protease-activated receptor-2 (NHMRC Project Grant administered by MSHHS via the PA Hospital)
    Metro South Hospital and Health Service
    Open grant

Supervision

Availability

Dr Jacky Suen is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    An investigation of Veno-Arterial Extracorporeal Membrane Oxygenation (V-A ECMO) and its interaction with Continuous Renal Replacement Therapy (CRRT)

    Principal Advisor

  • Doctor Philosophy

    The importance of blood flow pattern on ECMO and cardiogenic shock

    Associate Advisor

  • Doctor Philosophy

    Load-Independent Right Ventricular Assessment by Echocardiography

    Associate Advisor

  • Doctor Philosophy

    Vascular Endothelial Injury, Repair and Preconditioning in the Artificial Circulation

    Associate Advisor

Completed supervision

Media

Enquiries

Contact Dr Jacky Suen directly for media enquiries about:

  • Critical Care Medicine
  • ECMO
  • Extracorporeal Membrane Oxygenation
  • Heart Failure
  • Heart transplant
  • Respiratory Failure

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au